JANUS HENDERSON GROUP PLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$360,951,709
+4.2%
3,854,533
-0.7%
0.24%
+9.8%
Q2 2023$346,451,577
-8.5%
3,881,362
+9.9%
0.22%
-14.0%
Q1 2023$378,818,407
-14.9%
3,532,830
-3.0%
0.25%
-21.4%
Q4 2022$445,045,721
+12.2%
3,643,955
-52.5%
0.32%
+7.1%
Q3 2022$396,591,195
+10.5%
7,673,516
+98.7%
0.30%
+19.8%
Q2 2022$358,967,000
-10.4%
3,861,259
+13.1%
0.25%
+27.8%
Q1 2022$400,826,000
-7.5%
3,415,527
+6.1%
0.19%
+7.2%
Q4 2021$433,182,000
-16.4%
3,219,965
-1.0%
0.18%
-20.3%
Q3 2021$518,306,000
+26.0%
3,251,667
+4.0%
0.23%
+29.0%
Q2 2021$411,387,000
+0.8%
3,127,171
-1.3%
0.18%
-5.4%
Q1 2021$408,212,000
-18.7%
3,167,312
+5.3%
0.19%
-20.2%
Q4 2020$501,805,000
+9.6%
3,008,829
+1.4%
0.23%
-2.5%
Q3 2020$457,800,000
+27.7%
2,966,606
+22.4%
0.24%
+18.9%
Q2 2020$358,607,000
+70.6%
2,424,688
+29.9%
0.20%
+38.6%
Q1 2020$210,264,000
+20.6%
1,867,190
+49.0%
0.14%
+62.9%
Q4 2019$174,318,000
+454.7%
1,253,004
+284.1%
0.09%
+423.5%
Q3 2019$31,424,000
+104.0%
326,242
-41.2%
0.02%
+70.0%
Q2 2017$15,403,000554,8650.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2021
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders